-- 周一上午晚些时候，美国存托凭证（ADR）开盘走低，欧洲股市在美国交易。标普欧洲精选ADR指数下跌0.70%，至1803.50点。 欧洲大陆方面，领涨的股票包括半导体公司Sequans Communications (SQNS)和生物制药公司argenx (ARGX)，分别上涨8.1%和1.9%。紧随其后的是石油炼制公司Equinor (EQNR)和生物制药公司Grifols (GRFS)，分别上涨1.8%和1.5%。 欧洲大陆方面，领跌的股票包括制药公司赛诺菲 (SNY)和银行Banco Bilbao Vizcaya Argentaria (BBVA)，分别下跌5.5%和4.2%。紧随其后的是医疗器械制造商EDAP TMS (EDAP)和生物制药公司Cellectis (CLLS)，分别下跌3.3%和1%。 英国涨幅居前的股票包括生物制药公司Akari Therapeutics (AKTX)和生物技术公司Autolus Therapeutics (AUTL)，分别上涨9.2%和2.8%。紧随其后的是生物制药公司Biodexa Pharmaceuticals (BDRX)和Amarin (AMRN)，分别上涨2.3%和2.2%。 英国和爱尔兰跌幅居前的股票包括生物制药公司NuCana (NCNA)和邮轮运营商Carnival (CUK)，分别下跌2.2%和1.6%。紧随其后的是制药公司葛兰素史克 (GSK)和生物技术公司Trinity Biotech (TRIB)，分别下跌1.2%和0.4%。
Related Articles
Mining & Metals
Aya Gold & Silver Lists Its Shares on the Nasdaq Exchange
Aya Gold & Silver's (AYA.TO, AYA) on Monday said its shares are now trading on Nasdaq under the ticker symbol "AYA".With the start of trading on Nasdaq, the company's shares are no longer traded on the OTCQX market.The company's shares will continue to trade on the Toronto Stock Exchange under the symbol "AYA", it added."Access to the U.S. capital markets through Nasdaq is an exciting milestone for Aya as we close a record year and advance our growth strategy, supported by our attractive precious metals portfolio," said chief executive Benoit La Salle. "This listing is expected to increase the visibility of our shares and expand our shareholder base as we continue executing on our development plans."The company's shares were last seen down $1.31 to $23.75 on the Toronto Stock Exchange.Price: $23.73, Change: $-1.33, Percent Change: -5.31%
$AYA$AYA.TO
Australia
Sector Update: Consumer
Consumer stocks were lower Monday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) each falling about 1%.In corporate news, GameStop (GME) has proposed to acquire eBay (EBAY) in a cash-and-stock deal worth about $55.5 billion. GameStop fell past 7%, and eBay jumped 5.4%.
$EBAY$GME
Research
Research Alert: CFRA Maintains Buy Opinion On Shares Of Vici Properties Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our target by $1 to $34, based on a P/FFO of 11.8x our 2026 estimate, in line with VICI's three-year average multiple (11.8x). We increase our 2026 FFO forecast by $0.06 to $2.89 and 2027's by $0.03 to $2.96. VICI has maintained strong investment momentum in the past two quarters, announcing over $1B new capital commitments in consecutive quarters for the first time. The One Beverly Hills project loan, now totaling $1.5B, provides exposure to an ultra-high-end consumer market in the non-gaming space. Management has now hedged the majority of interest rate risk through 2027 as it works to de-risk the balance sheet. After a down year in Las Vegas in 2025, our expectations are for stronger travel this year. We also note there are now two significant long-term growth drivers, with the A's new stadium opening in Las Vegas in 2028 and the potential for an NBA expansion team in 2029-2030 looking more favorable, per NBA commissioner Adam Silver.
$VICI